| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
634 |
592 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,690 |
1,484 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
669 |
538 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
492 |
412 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
119 |
116 |
$6K |
| 87428 |
|
250 |
170 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
60 |
56 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
97 |
91 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
692 |
304 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
16 |
$820.03 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
80 |
38 |
$65.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
88 |
83 |
$55.56 |
| 87807 |
|
12 |
12 |
$11.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
43 |
38 |
$0.00 |